Shandong Oriental Ocean Sci-Tech Co.,Ltd. (002086.SZ) announced that its subsidiary, Mass Spectrometry Biotechnology Co., Ltd., has received registration approval from the Shandong Provincial Medical Products Administration for its self-developed methotrexate detection reagent (liquid chromatography-tandem mass spectrometry method). The subsidiary has now obtained the medical device registration certificate.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments